Brewin Dolphin LTD Avalo Therapeutics, Inc. Transaction History

Brewin Dolphin LTD

  • $2.08 Billion
  • Q2 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Nov 14, 2022
SELL
$3.0 - $10.45 $27,900 - $97,185
-9,300 Closed
0 $0
Q1 2022

Nov 14, 2022
BUY
$7.57 - $21.72 $70,401 - $201,996
9,300 New
9,300 $7,000
Q3 2021

Nov 09, 2023
BUY
$26.16 - $40.68 $243,288 - $378,324
9,300 New
9,300 $20.3 Million

Others Institutions Holding AVTX

# of Institutions
1
Shares Held
34.6K
Call Options Held
0
Put Options Held
0
View Full List

About Avalo Therapeutics, Inc.

AVTX Quotes by TradingView
  • Ticker AVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,414,100
  • Market Cap $117M
  • Description
  • Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the tr...
More about AVTX
Track This Portfolio

Track Brewin Dolphin LTD Portfolio

Follow Brewin Dolphin LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email